Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|March 27, 2026
The pyruvate branch point controls lymphoid cancer cell disseminationHamidullah Khan, Steven John, Sushmita Roy, et al.JCI Insight|April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinomaUsha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2006
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitisMichael D Rollins, Sharon Sudarshan, Matthew A Firpo, et al.International Journal of Radiation Oncology, Biology, Physics|February 10, 2015
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusionMatthew J Nyflot, Tim J Kruser, Anne M Traynor, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.International Journal of Molecular Sciences|May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast CancerMari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.Blood|April 12, 2014
TPL2 kinase regulates the inflammatory milieu of the myeloma nicheChelsea Hope, Samuel J Ollar, Erika Heninger, et al.Immunity|February 22, 2011
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formationShelly M Wuerzberger-Davis, Yuhong Chen, David T Yang, et al.Clinical Lymphoma, Myeloma & Leukemia|December 2, 2017
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network StudyJulie E Chang, Lakeesha L Carmichael, KyungMann Kim, et al.Frontiers in Oncology|May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.Pageof 9